| Oral anticoagulant treatment in patients with atrial fibrillation and chronic kidney disease MC Stoica, Z Gall, ML Gliga, CD Căldăraru, O Szekely Medicina 57 (5), 422, 2021 | 7 | 2021 |
| Correlations between the stages of kidney disease and the pharmacokinetic parameters of orally administered ciprofloxacin at patients with chronic kidney disease MC Stoica, CE Vari, S Imre, S Vancea, MT Dogaru, E Cara, D Tar Farmacia 63, 6, 2015 | 4 | 2015 |
| Some Models of Chronic Kidney Disease Induced in the Experimental Animal MC Stoica, ML Gliga, CD Căldăraru Acta Medica Transilvanica 26 (4), 53-55, 2021 | | 2021 |
| The patient, the OTC drug, and the pharmacist–an (in) separable triad? A critical analysis of self-medication CE VARI, ÖSZ Bianca-Eugenia, G JÎTCĂ, A GROȘAN, MC STOICA Romanian Journal of PHARMACEUTICAL PRACTICE| Vol. XIV 58 (3), 2021 | | 2021 |
| LIPID DISORDERS IN KIDNEY TRANSPLANTATION: A PERSISTENT CONUNDRUM. IS THERE ANY CONNECTION WITH IMMUNOSUPPRESSIVE THERAPY? ID TARŢA¹, CD CĂLDĂRARU, MT Dogaru, E CARAŞCA, C TARŢA, ... Farmacia 64 (5), 2016 | | 2016 |
| The Monitoring of Immunosuppressive Therapy with Tacrolimus in Patients with Kidney Transplant, Based on the Pharmacokinetic Criteria SC Mihai, CC Denise, VC Eugen, TD Ionuţ, DM Titica, C Emilian, ... Acta Marisiensis-Seria Medica 61 (4), 265-268, 2015 | | 2015 |
| MONITORING THE ANTIMICROBIAL THERAPY OF THE PATIENT WITH CHRONIC KIDNEY DISEASE USING THE PHARMACOKINETIC CRITERIA MC STOICA, CD CĂLDĂRARU, CE VARI, S VANCEA, MT DOGARU, ... | | |
